# Social Anxiety Disorder (SAD) FDA approvals and PDUFA dates

Canonical: https://sec-api.dev/indications/social-anxiety-disorder-sad

> 2 upcoming FDA catalysts in social Anxiety Disorder (SAD): VQW-765 (VNDA) on December 2026 (primary completion); VQW-765 (VNDA) on Dec 2026 to Mar 2027 (topline data readout).

Data as of November 16, 2026 (snapshot 20261116T222116Z). Every date quotes the SEC filing or FDA page it came from. Date precision: exact day, month only, quarter only.

**Free:** every drug page and the next 30 days of the FDA calendar, no account. Calendar API, alerts when a date moves, and full history: https://sec-api.dev/pricing . Free API key: https://sec-api.dev/sign-up?ref=ai-claudebot

## Catalysts

| Date | Event | Ticker | Indication | Status | Source sentence |
| --- | --- | --- | --- | --- | --- |
| April 21, 2026 | [Fasedienol nasal spray primary completion](https://sec-api.dev/pdufa/fasedienol-nasal-spray) | VTGN | Social Anxiety Disorder (SAD) | completed | "NCT06615557 (Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4)): Overall Status COMPLETED; Phase PHASE3; Primary Completion 2026-04-21 (ACTUAL); Lead Sponsor VistaGen Therapeutics, Inc.." ([ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT06615557)) |
| December 2026 | [VQW-765 primary completion](https://sec-api.dev/pdufa/vqw-765) | VNDA | Social Anxiety Disorder (SAD) | scheduled | "NCT07221578 (Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Social Anxiety Disorder): Overall Status ACTIVE_NOT_RECRUITING; Phase PHASE3; Primary Completion 2026-12 (ESTIMATED); Lead Sponsor Vanda Pharmaceuticals." ([ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT07221578)) |
| Dec 2026 to Mar 2027 | [VQW-765 topline data readout](https://sec-api.dev/pdufa/vqw-765) | VNDA | Social Anxiety Disorder (SAD) | scheduled | "NCT07221578 (Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Social Anxiety Disorder): Overall Status ACTIVE_NOT_RECRUITING; Phase PHASE3; Primary Completion 2026-12 (ESTIMATED); Lead Sponsor Vanda Pharmaceuticals." ([ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT07221578)) |

## Drugs

- [Fasedienol nasal spray](https://sec-api.dev/pdufa/fasedienol-nasal-spray) (VTGN)
- [VQW-765](https://sec-api.dev/pdufa/vqw-765) (VNDA)

## Feeds and downloads

- Subscribe (iCal): https://sec-api.dev/indications/social-anxiety-disorder-sad.ics
- Next 30 days as CSV: https://sec-api.dev/fda-calendar.csv . JSON: https://sec-api.dev/fda-calendar.json . All events (iCal): https://sec-api.dev/fda-calendar.ics
- New or moved PDUFA dates: https://sec-api.dev/pdufa-dates/feed.xml (RSS), https://sec-api.dev/pdufa-dates/feed.json (JSON Feed)
- FDA approvals: https://sec-api.dev/fda-approvals-today/feed.xml (RSS), https://sec-api.dev/fda-approvals-today/feed.json (JSON Feed)
- License: CC BY 4.0 for the public 30-day window (https://sec-api.dev/biotech/license.txt). Full history: https://sec-api.dev/pricing

## Cite this page

sec-api.dev. "Social Anxiety Disorder (SAD) FDA approvals and PDUFA dates." Biotech catalyst calendar, data as of November 16, 2026 (snapshot 20261116T222116Z). https://sec-api.dev/indications/social-anxiety-disorder-sad

```bibtex
@misc{secapidev_indications_social_anxiety_disorder_sad_20261116,
  title        = {Social Anxiety Disorder (SAD) FDA approvals and PDUFA dates},
  author       = {{sec-api.dev}},
  year         = {2026},
  month        = {nov},
  howpublished = {\url{https://sec-api.dev/indications/social-anxiety-disorder-sad}},
  note         = {Biotech catalyst calendar, data as of 2026-11-16, snapshot 20261116T222116Z. Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source.}
}
```

```json
{"type":"dataset","id":"secapidev_indications_social_anxiety_disorder_sad_20261116","title":"Social Anxiety Disorder (SAD) FDA approvals and PDUFA dates","publisher":"sec-api.dev","URL":"https://sec-api.dev/indications/social-anxiety-disorder-sad","issued":{"date-parts":[[2026,11,16]]},"version":"20261116T222116Z","license":"https://creativecommons.org/licenses/by/4.0/","note":"Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source."}
```

---
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Food and Drug Administration or the U.S. Securities and Exchange Commission. Dates are as stated by sponsors and FDA; the FDA can act before or after a target date. Not investment advice.
